BioBlast Pharma Ltd, a clinical stage biotechnology company focusing on therapies for rare genetic diseases, is celebrating its recent IPO and the end of its quiet period with a visit to the NASDAQ MarketSite in Times Square. CEO Dr. Dalia ...

Macrocure Ltd., a clinical-stage biotech company developing treatments for chronic and hard-to-heal wounds, recently announced second quarter financial results. Highlights noted in the fiscal summary include: In June, a meeting with the Data Safety Monitoring Board (DSMB) resulted in an advisement ...